Scientists peek inside liver to see how chemo wakes up immune cells against eye cancer
NCT ID NCT07364474
First seen Jan 26, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study looks at how the liver's immune system responds to a chemotherapy drug called melphalan, given directly to the liver through a special procedure. Ten adults with eye melanoma that has spread to the liver will have small tumor samples taken before and after treatment to measure changes in immune cells. The goal is to learn more about the liver's immune environment, not to test a new cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.